Literature DB >> 16710727

[Social anxiety disorders].

B Renneberg1, A Ströhle.   

Abstract

A main feature of social anxiety disorders is the fear or avoidance of social situations in which one is the center of attention and fears criticism or negative judgement. According to current diagnostic systems, three types of these disorders can be classified: specific social phobia, generalised social phobia, and avoidant personality disorder. Social anxiety disorders are prevalent mental disorders (lifetime prevalence up to 13%). Other mental disorders often appear together with them. Following the criteria for evidence-based medicine, psychotherapeutic and pharmacologic interventions are described. Regarding psychotherapeutic approaches, the best results have been seen with cognitive-behavioural methods. Among psychopharmacologic treatments, selective serotonin reuptake inhibitors and the selective noradrenalin reuptake inhibitor Venlafaxin are the first-choice treatments.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16710727     DOI: 10.1007/s00115-006-2087-x

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  21 in total

1.  Bupropion-SR in treatment of social phobia.

Authors:  N P Emmanuel; O Brawman-Mintzer; W A Morton; S W Book; M R Johnson; J P Lorberbaum; J C Ballenger; R B Lydiard
Journal:  Depress Anxiety       Date:  2000       Impact factor: 6.505

2.  The treatment of social anxiety disorder.

Authors:  Thomas L Rodebaugh; Robert M Holaway; Richard G Heimberg
Journal:  Clin Psychol Rev       Date:  2004-11

3.  Treatment of social phobia with gabapentin: a placebo-controlled study.

Authors:  A C Pande; J R Davidson; J W Jefferson; C A Janney; D J Katzelnick; R H Weisler; J H Greist; S M Sutherland
Journal:  J Clin Psychopharmacol       Date:  1999-08       Impact factor: 3.153

4.  Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study.

Authors:  Siegfried Kasper; Dan J Stein; Henrik Loft; Rico Nil
Journal:  Br J Psychiatry       Date:  2005-03       Impact factor: 9.319

5.  Psychological and pharmacological treatments of social phobia: a meta-analysis.

Authors:  I C Fedoroff; S Taylor
Journal:  J Clin Psychopharmacol       Date:  2001-06       Impact factor: 3.153

6.  Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.

Authors:  Michael R Liebowitz; Alan J Gelenberg; Dennis Munjack
Journal:  Arch Gen Psychiatry       Date:  2005-02

7.  Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial.

Authors:  M B Stein; M R Liebowitz; R B Lydiard; C D Pitts; W Bushnell; I Gergel
Journal:  JAMA       Date:  1998-08-26       Impact factor: 56.272

Review 8.  WCA recommendations for the long-term treatment of social phobia.

Authors:  Michael Van Ameringen; Christer Allgulander; Borwin Bandelow; John H Greist; Eric Hollander; Stuart A Montgomery; David J Nutt; Ahmed Okasha; Mark H Pollack; Dan J Stein; Richard P Swinson
Journal:  CNS Spectr       Date:  2003-08       Impact factor: 3.790

9.  Tranylcypromine in social phobia.

Authors:  M Versiani; F D Mundim; A E Nardi; M R Liebowitz
Journal:  J Clin Psychopharmacol       Date:  1988-08       Impact factor: 3.153

10.  Pharmacological treatment of social anxiety disorder: a meta-analysis.

Authors:  Carlos Blanco; Franklin R Schneier; Andrew Schmidt; Carmen-Rosa Blanco-Jerez; Randall D Marshall; Arturo Sánchez-Lacay; Michael R Liebowitz
Journal:  Depress Anxiety       Date:  2003       Impact factor: 6.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.